Gabapentin can significantly improve dystonia severity and quality of life in children.

[1]  Jean-Pierre Lin,et al.  Interventional studies in childhood dystonia do not address the concerns of children and their carers. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[2]  K. Ashkan,et al.  Evaluation of functional goal outcomes using the Canadian Occupational Performance Measure (COPM) following Deep Brain Stimulation (DBS) in childhood dystonia. , 2014, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[3]  Jean-Pierre Lin,et al.  The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  J. Winkelman,et al.  Comparison of pregabalin with pramipexole for restless legs syndrome. , 2014, The New England journal of medicine.

[5]  Jean-Pierre Lin,et al.  Status dystonicus: a practice guide , 2014, Developmental medicine and child neurology.

[6]  Jean-Pierre Lin,et al.  Dystonia Severity Action Plan: a simple grading system for medical severity of status dystonicus and life‐threatening dystonia , 2013, Developmental medicine and child neurology.

[7]  M. Hallett,et al.  Phenomenology and classification of dystonia: A consensus update , 2013, Movement disorders : official journal of the Movement Disorder Society.

[8]  K. Ashkan,et al.  Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia , 2013, Developmental medicine and child neurology.

[9]  M. Hellmich,et al.  Effects of deep brain stimulation in dyskinetic cerebral palsy: A meta‐analysis , 2013, Movement disorders : official journal of the Movement Disorder Society.

[10]  Jean-Pierre Lin,et al.  Functional priorities in daily life for children and young people with dystonic movement disorders and their families. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[11]  R. Selway,et al.  Beyond the Burke-Fahn-Marsden Dystonia Rating Scale: deep brain stimulation in childhood secondary dystonia. , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[12]  J. Zacny,et al.  Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers , 2012, Pharmacology Biochemistry and Behavior.

[13]  F. Kirkham,et al.  Movement disorder emergencies in childhood. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[14]  L. Bailey,et al.  Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus , 2011, Movement disorders : official journal of the Movement Disorder Society.

[15]  M. Safavi,et al.  Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[16]  S. Pradhan,et al.  Gabapentin as a rescue drug in D-penicillamine-induced status dystonicus in patients with Wilson disease. , 2010, Neurology India.

[17]  G. Defazio.  The epidemiology of primary dystonia: current evidence and perspectives , 2010, European journal of neurology.

[18]  Stephen J. Smith,et al.  Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis , 2009, Cell.

[19]  P. Starr,et al.  Induction of Bradykinesia with Pallidal Deep Brain Stimulation in Patients with Cranial-Cervical Dystonia , 2009, Stereotactic and Functional Neurosurgery.

[20]  M. Hallett,et al.  The pathophysiological basis of dystonias , 2008, Nature Reviews Neuroscience.

[21]  Annette C. Dolphin,et al.  Functional biology of the α 2 δ subunits of voltage-gated calcium channels , 2007 .

[22]  S. Bressman,et al.  The diagnosis of dystonia , 2006, The Lancet Neurology.

[23]  G. Thickbroom,et al.  Gabapentin can improve postural stability and quality of life in primary orthostatic tremor , 2005, Movement disorders : official journal of the Movement Disorder Society.

[24]  D. Dressler,et al.  Autonomic Side Effects of Botulinum Toxin Type B Treatment of Cervical Dystonia and Hyperhidrosis , 2002, European Neurology.

[25]  G. Filippini,et al.  Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study , 2002, Neurology.

[26]  P. Kam,et al.  Gabapentin: pharmacology and its use in pain management , 2002, Anaesthesia.

[27]  D. Calne,et al.  The long-term response to levodopa in dopa-responsive dystonia. , 2001, Parkinsonism & related disorders.

[28]  S. Campbell,et al.  Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy , 2000 .

[29]  E. Roach,et al.  Gabapentin for familial paroxysmal dystonic choreoathetosis , 1997, Neurology.

[30]  R. Palisano,et al.  Development and reliability of a system to classify gross motor function in children with cerebral palsy , 1997, Developmental medicine and child neurology.

[31]  S. Fahn,et al.  Spread of symptoms in idiopathic torsion dystonia , 1995, Movement disorders : official journal of the Movement Disorder Society.

[32]  C D Marsden,et al.  Dopa‐responsive dystonia , 1991, Neurology.

[33]  S. Fahn.  High dosage anticholinergic therapy in dystonia , 1983, Neurology.

[34]  Susanne Iwarsson,et al.  International Classification of Functioning , 2014 .